Journals / Middle Black Sea Journal of Health Science / 2019 / Cilt: 5 - Sayı: 3

The Factors Affecting Smoking Cessation and Efficacy of Quitting Methods

Pages
168–174
Publication Date
2019-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was found that being married and having no additional disease significantly increased smoking cessation rate (p = 0.049, p = 0.010, respectively).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We aimed to compare the demographic-sociocultural characteristics of quitting and non-quitting individuals and to evaluate the factors affecting smoking cessation and success rates of treatment methods.Methods: 179 patients were included in the study.
📊
Key Findings & Data:Statistical analysis was performed using Statistical Package for Social Sciences Version 21.0 (SPSS-21.0).
💡
Conclusion & Impact:It was found that being married and having no additional disease significantly increased smoking cessation rate (p = 0.049, p = 0.010, respectively).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:smoking addiction · smoking cessation

Abstract

Objective: We aimed to compare the demographic-sociocultural characteristics of quitting and non-quitting individuals and to evaluate the factors affecting smoking cessation and success rates of treatment methods.Methods: 179 patients were included in the study. Demographic characteristics, smoking behaviour, Fagerström nicotine dependence level were recorded. The treatment results at the end of the first year were evaluated. The efficacy of treatment methods used in the treatment of smoking dependence, gender, occupation, education, comorbidity, and family history were recorded in quitting and non-quitting individuals. Statistical analysis was performed using Statistical Package for Social Sciences Version 21.0 (SPSS-21.0). Results: Of the 179 patients evaluated, 118 (65.6%) were male and 71 (39.7%) were married. The mean age was 41.5 ± 13.7 years. At the end of 12 months follow-up, 57 (31.8%) had been quitted smoking. There was no difference between the quit and non-quit groups in terms of gender, age, working status and education level. It was found that being married and having no additional disease significantly increased smoking cessation rate (p = 0.049, p = 0.010, respectively). In both groups, combination of behavioural treatment and varenicline was the most common method. There was no significant difference among the pharmacological methods used. Conclusion: In our study, smoking cessation rate was found to be 31.8%. The efficacy of different treatment modalities was similar. Despite the current treatments, the rate of smoking cessation is not at the desired level and further studies are needed to develop new methods for smoking cessation treatment.

🔖

Cite This Article

GÜLENSOY, E. S., AKPINAR, E. E. (2019). The Factors Affecting Smoking Cessation and Efficacy of Quitting Methods. Middle Black Sea Journal of Health Science, Cilt: 5 - Sayı: 3, 168–174. https://ajindex.com/articles/791157

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Arguder E, Karezli A, Hezer H, Kılıc H, Er M, Hasanoglu HC, et al. Factors Affecting the Success of Smoking Cessation. Turk Thorac J 2013;14:81-87
  2. Bize R, Willi C, Chiolero A, Stoianov R. Participation in a population-based physical activity programme as an aid for smoking cessation: randomized trial. Tobacco Control 2010; 19:488-494
  3. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2010; 8;(12):CD006103. Can G, Oztuna F, Ozlu T. The Evaluation of Outpatient Smoking Cessation Clinic Results Tuberculosis and Thorax 2004;52: 69-74,
  4. Carlson LE, Goodey E, Bennet MH, Taenzer B. The addition of social support to a community-based large-group behavioral smoking cessation intervention: Improved cessation rates and gender differences. Addictive Behaviors 2002;27:547–559
  5. Chandola T, Head J, Bartley M. Socio-demographic predictors of quitting smoking: how important are household factors? Addiction. 2004;99(6):770-777 Demir T. Common psychiatric disorders in Turkey. Symposium series 2008; 62:231-238
  6. Evins AE, Carter C, Culhane MA, Birnbaum A, Horowitz J, Hsieh H, et al. A 12-week double-blind, placebo-controlled study of Bupropion SR added to high dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia, J Clin Pyscopharmacol. 2007 27 (4):380-386
  7. Fiore MC, Baker TB. Treating Smokers in the Health Care Setting, N Engl J Med 2011;365:1222-1231
  8. Fiore MC, Smith SS, Jorenby DE, Baker TB. The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. JAMA 271: 1940-7, 1994
  9. Freid VM, Prager K, Mackay AP, Xia H. Chartbook on Trends in the Health of Americans. National Center for Health Statistics, Hyattsville, Maryland: 2003
  10. Global Adult Tobacco Survey, Turkey, 2016. (cited 2019 August 5) Available from: https://nccd.cdc.gov/GTSSDataSurveyResources/Ancillary/DownloadAttachment.aspx?ID=3452 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guidelines 2011 www.goldcopd.org Global Youth Tobacco Survey, Turkey, 2017. (cited 2019 August 5) Available from: https://extranet.who.int/ncdsmicrodata/index.php/catalog/477
  11. Godfresten NS, Lam TH, Hansel TT, Leon ME, Gray N, Dresler C et al. COPD-related morbidity and mortality after smoking cessation: status of evidence. Eur Respir J 2008, 32:844-53.
  12. Hays JT, Hurt RD, Rigotti NA, Niaura R, Gonzales D, Durcan MJ, Sachs DP, Wolter TD, Buist AS, Jonhston JA, White JD, Sustained release Bupropion for pharmacologi